Published in Scand J Thorac Cardiovasc Surg on January 01, 1993
Increased expression of cyclooxygenase 2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res (1998) 3.20
Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group. Oncogene (1990) 2.97
Mutations of the p53 gene as a predictor of poor prognosis in patients with non-small-cell lung cancer. J Natl Cancer Inst (1993) 2.66
Bronchial arterial infusion is an effective therapeutic modality for centrally located early-stage lung cancer: results of a pilot study. Chest (1999) 2.12
Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer. Chest (1993) 2.06
The number of lymph node metastases influences survival in esophageal cancer. J Surg Oncol (1998) 1.78
The role of video-assisted thoracic surgery for the treatment of lung cancer: lung lobectomy by thoracoscopy versus the standard thoracotomy approach. Int Surg (2000) 1.76
Frequency and diversity of p53 mutations in childhood rhabdomyosarcoma. Cancer Res (1992) 1.72
Cyclooxygenase-2 inhibitor induces apoptosis and enhances cytotoxicity of various anticancer agents in non-small cell lung cancer cell lines. Clin Cancer Res (2000) 1.64
Mechanisms of resistance to cis-diamminedichloroplatinum (II) in a rat ovarian carcinoma cell line. Eur J Cancer Clin Oncol (1989) 1.64
Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. Oncogene (1992) 1.63
An evaluation study of EGFR mutation tests utilized for non-small-cell lung cancer in the diagnostic setting. Ann Oncol (2012) 1.63
Gene-environment interaction between an aldehyde dehydrogenase-2 (ALDH2) polymorphism and alcohol consumption for the risk of esophageal cancer. Carcinogenesis (2001) 1.59
Plasma thrombospondin levels in patients with colorectal carcinoma. Cancer (1998) 1.57
Which biomarker predicts benefit from EGFR-TKI treatment for patients with lung cancer? Br J Cancer (2007) 1.55
Inflammatory pseudotumor of the lung in adults: radiographic and clinicopathological analysis. Ann Thorac Surg (1989) 1.53
Correlation of intrinsic chemoresistance of non-small-cell lung cancer cell lines with HER-2/neu gene expression but not with ras gene mutations. J Natl Cancer Inst (1993) 1.50
Prognostic significance of elevated cyclooxygenase 2 expression in primary, resected lung adenocarcinomas. Clin Cancer Res (1999) 1.47
High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogene (1992) 1.41
Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res (1996) 1.41
Detection of chromogranin A mRNA in small cell lung carcinoma using a new, highly sensitive in situ hybridization method with a non-radioisotope oligonucleotide probe. Cancer (1998) 1.40
Nonneoplastic and nonhyperplastic thymus in myasthenia gravis. An immunohistochemical study with double immunoenzymatic labeling of basement membrane and cellular components. Am J Clin Pathol (1990) 1.40
A small polypoid lesion in the lower common bile duct: a case study. Endoscopy (1994) 1.39
Lymphangioma in the small intestine: report of a case and review of the Japanese literature. Surg Today (1992) 1.38
Video-assisted thoracoscopic esophagectomy for esophageal cancer. Surg Endosc (1999) 1.33
Immunohistochemical evidence of autocrine growth factors in adenocarcinoma of the human lung. Cancer Res (1990) 1.33
Polymorphism at codon 213 within the p53 gene. Oncogene (1991) 1.30
Methylation of the 5' CpG island of the FHIT gene is closely associated with transcriptional inactivation in esophageal squamous cell carcinomas. Cancer Res (1998) 1.28
Video-assisted thoracoscopic surgery (VATS) segmentectomy for small peripheral lung cancer tumors: intermediate results. Surg Endosc (2004) 1.26
Completely resected stage IIIA non-small cell lung cancer: the significance of primary tumor location and N2 station. J Thorac Cardiovasc Surg (2001) 1.22
Carcinosarcoma and spindle cell carcinoma of the lung. Clinicopathologic and immunohistochemical studies. J Thorac Cardiovasc Surg (1990) 1.20
Clinicopathological analysis of 143 primary malignant lymphomas in the small and large intestines based on the new WHO classification. Histopathology (2003) 1.19
Occupational lung cancer among copper smelters. Int J Cancer (1974) 1.17
Surgical implications of the new IASLC/ATS/ERS adenocarcinoma classification. Eur Respir J (2011) 1.16
Mutations in the p53 gene in primary human breast cancers. Cancer Res (1991) 1.15
Disproportionate representation of KRAS gene mutation in atypical adenomatous hyperplasia, but even distribution of EGFR gene mutation from preinvasive to invasive adenocarcinomas. J Pathol (2007) 1.15
Frequent allelic imbalance suggests involvement of a tumor suppressor gene at 1p36 in the pathogenesis of human lung cancers. Genes Chromosomes Cancer (2000) 1.15
A clinicopathological study of gastric cancer with special reference to age of the patients: an analysis of 1,630 cases. World J Surg (1989) 1.13
Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Eur J Cancer (1991) 1.09
Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res (1996) 1.07
K-ras and p53 mutations are an independent unfavourable prognostic indicator in patients with non-small-cell lung cancer. Br J Cancer (1997) 1.05
Expression of vascular endothelial growth factors (VEGF-A/VEGF-1 and VEGF-C/VEGF-2) in postmenopausal uterine endometrial carcinoma. Gynecol Oncol (2001) 1.05
Characteristic radiographic features of pulmonary carcinoma associated with large bulla. Ann Thorac Surg (1988) 1.04
High frequency of clonally related tumors in cases of multiple synchronous lung cancers as revealed by molecular diagnosis. Clin Cancer Res (2000) 1.04
Overall survival and local recurrence of 406 completely resected stage IIIa-N2 non-small cell lung cancer patients: questionnaire survey of the Japan Clinical Oncology Group to plan for clinical trials. Lung Cancer (2001) 1.04
Dietary factors and lung cancer risk in Japanese: with special reference to fish consumption and adenocarcinomas. Br J Cancer (2001) 1.03
Lymphomatous polyposis of the gastrointestinal tract, including mantle cell lymphoma, follicular lymphoma and mucosa-associated lymphoid tissue lymphoma. Histopathology (2005) 1.00
Low rate of apoptosis and overexpression of bcl-2 in Epstein-Barr virus-associated gastric carcinoma. Histopathology (1999) 1.00
Benign epithelial cyst of the spleen with a high production of carbohydrate antigen 19-9. Int Surg (1999) 1.00
High-yield synthesis of ultrathin metal nanowires in carbon nanotubes. Angew Chem Int Ed Engl (2009) 0.99
Atypical lipoma of the lung. Thorax (1991) 0.98
Thoracoscopic approach to the diagnosis and treatment of diaphragmatic disorders. Surg Laparosc Endosc (1996) 0.98
Immunological quantitation of DT-diaphorase in carcinoma cell lines and clinical colon cancers: advanced tumors express greater levels of DT-diaphorase. Jpn J Cancer Res (1998) 0.98
Expression of four CEA family antigens (CEA, NCA, BGP and CGM2) in normal and cancerous gastric epithelial cells: up-regulation of BGP and CGM2 in carcinomas. Int J Cancer (1998) 0.98
Serum level and tissue expression of c-erbB-2 protein in lung adenocarcinoma. Chest (1995) 0.98
Chronic expanding hematoma in the chest. J Cardiovasc Surg (Torino) (2000) 0.97
Malignant transformation of an intrathoracic neurofibroma in von Recklinghausen's disease. Scand Cardiovasc J (1998) 0.97
Detailed deletion mapping suggests the involvement of a tumor suppressor gene at 17p13.3, distal to p53, in the pathogenesis of lung cancers. Oncogene (1998) 0.97
Predictive factors associated with prolonged survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib. Br J Cancer (2007) 0.96
Discrimination of double primary lung cancer from intrapulmonary metastasis by p53 gene mutation. Br J Cancer (1999) 0.96
Apoptosis and proliferation in gastric carcinoma: the association with histological type. Histopathology (1996) 0.95
p53 nuclear immunostaining and gene mutations in non-small-cell lung cancer and their effects on patient survival. Ann Oncol (1995) 0.95
Clinical implications of p53 autoantibodies in the sera of patients with non-small-cell lung cancer. J Natl Cancer Inst (1998) 0.95
Factors related to the relapse of bronchiolitis obliterans organizing pneumonia. Chest (1998) 0.94
Relationship between Fas-ligand expression on carcinoma cell and cytotoxic T-lymphocyte response in lymphoepithelioma-like cancer of the stomach. Int J Cancer (1999) 0.94
p27KIP1 in human lung cancers: differential changes in small cell and non-small cell carcinomas. Cancer Res (1998) 0.94
Detection of CYP1A1 gene polymorphism using designed RFLP and distributions of CYP1A1 genotypes in Japanese. Int Arch Occup Environ Health (1995) 0.94
Implantation of ultraflex nitinol stents in malignant tracheobronchial stenoses. Chest (2000) 0.93
Transgastrostomal endoscopic surgery for early gastric carcinoma and submucosal tumor. Surg Endosc (1999) 0.93
Cell cycle-regulated factors in esophageal cancer. Dis Esophagus (2002) 0.93
Papillary meningioma with pulmonary metastasis. Case report. J Neurosurg (1989) 0.93
Persistent increase in chromosome instability in lung cancer: possible indirect involvement of p53 inactivation. Am J Pathol (2001) 0.93
A novel germline p53 splicing mutation in a pediatric patient with a second malignant neoplasm. Oncogene (1993) 0.92
Low-grade metaplastic carcinoma of the thymus. Histopathology (1999) 0.92
Unfavorable prognosis of patients with stage II non-small cell lung cancer associated with macroscopic nodal metastases. Chest (1999) 0.92
Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles. Br J Cancer (2007) 0.92
Molecular genetic characterization of neuroendocrine lung cancer cell lines. Anticancer Res (1995) 0.92
Expression of human telomerase subunit genes in primary lung cancer and its clinical significance. Ann Thorac Surg (2000) 0.91
Free-form neutrophil elastase is an independent marker predicting recurrence in primary breast cancer. J Leukoc Biol (1995) 0.91
Population-based mapping of pulmonary adenoma susceptibility 1 locus. Cancer Res (2000) 0.91
Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers. Clin Cancer Res (1997) 0.90
Minamata disease (organic mercury poisoning): neuroradiologic and electrophysiologic studies. Neurology (1982) 0.90
Identification of a metastasis signature and the DLX4 homeobox protein as a regulator of metastasis by combined transcriptome approach. Oncogene (2007) 0.90
Mutations of the P53 tumor suppressor gene as clonal marker for multiple primary lung cancers. J Thorac Cardiovasc Surg (1997) 0.90
Hereditary and acquired p53 gene mutations in childhood acute lymphoblastic leukemia. J Clin Invest (1992) 0.90
Surgical resection for pulmonary metastases of sweat gland carcinoma. Thorax (1994) 0.89
Thoracoscopic transdiaphragmatic microwave coagulation therapy for a liver tumor. Surg Endosc (1998) 0.89
Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. Ann Thorac Surg (1997) 0.89
MUC1 mucin mRNA expression in stage I lung adenocarcinoma and its association with early recurrence. Ann Thorac Surg (1999) 0.89
Local increase in polymorphonuclear leukocyte elastase is associated with tumor invasiveness in non-small cell lung cancer. Chest (1996) 0.89
[Surgical treatment of renal cell carcinoma associated with pulmonary metastasis]. Nihon Gan Chiryo Gakkai Shi (1989) 0.88
Surgical treatment of lung cancer in the octogenarian. Ann Thorac Surg (1994) 0.88
Thoracoscopic lobectomy with systemic lymph node dissection for lymph node positive non-small cell lung cancer--is thoracoscopic lymph node dissection feasible? Thorac Cardiovasc Surg (2008) 0.88